Главные вкладки
В.И. Каледин
Ovchinnikova LP, Bogdanova LA, Kaledin VI. Mutagenic activation reduces carcinogenic activity of ortho-aminoazotoluene for mouse liver. Bull Exp Biol Med. 2013 Mar;154(5):664-8.
Godovikova TS, Lisitskiy VA, Antonova NM, Popova TV, Zakharova OD, Chubarov AS, Koptyug IV, Sagdeev RZ, Kaptein R, Akulov AE, Kaledin VI, Nikolin VP, Baiborodin SI, Koroleva LS, Silnikov VN. Ligand-directed acid-sensitive amidophosphate 5-trifluoromethyl-2'-deoxyuridine conjugate as a potential theranostic agent. Bioconjug Chem. 2013 May 15;24(5):780-95. doi: 10.1021/bc3006072. Epub 2013 Apr 16.
Koval OA, Fomin AS, Kaledin VI, Semenov DV, Potapenko MO, Kuligina EV, Nikolin VP, Nikitenko EV, Richter VA. A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models. Biochimie. 2012 Dec;94(12):2467-74. doi: 10.1016/j.biochi.2012.08.017. Epub 2012 Aug 30.
Pakharukova MY, Smetanina MA, Ilnitskaya SI, Kaledin VI, Merkulova TI. OAT and 3'MeDAB azo compounds similarly cause liver tumors in GR mice, but differently modify activities of FoxA transcription factors. Bull Exp Biol Med. 2011 Nov;152(1):101-4.
Amikashieva AV, Il'nitskaia SI, Nikolin VP, Popova NA, Kaledin VI. The effect of psychoemotional state on Lewis lung carcinoma metastasis. Ross Fiziol Zh Im I M Sechenova. 2012 Mar;98(3):417-23.
биомедицина, молекулярная медицина, канцерогенез